Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Mizuho Analyst Says

Cardinal Health (NYSE:CAH) had its price target raised by equities research analysts at Mizuho from $235.00 to $240.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Mizuho’s target price would suggest a potential upside of 5.28% from the company’s current price.

A number of other equities research analysts have also recently issued reports on CAH. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. UBS Group upped their price target on shares of Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research report on Monday. Wells Fargo & Company cut their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Morgan Stanley lifted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Finally, Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $251.73.

Cardinal Health Stock Up 0.9%

NYSE CAH opened at $227.96 on Thursday. Cardinal Health has a 12-month low of $137.75 and a 12-month high of $243.21. The firm’s 50 day moving average is $219.98 and its 200-day moving average is $214.43. The company has a market capitalization of $53.39 billion, a PE ratio of 34.86, a price-to-earnings-growth ratio of 1.11 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter last year, the firm earned $2.35 earnings per share. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts expect that Cardinal Health will post 10.77 EPS for the current year.

Institutional Trading of Cardinal Health

Institutional investors have recently modified their holdings of the stock. Norges Bank bought a new stake in Cardinal Health during the 4th quarter worth $790,344,000. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Marshall Wace LLP boosted its stake in shares of Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after purchasing an additional 884,648 shares in the last quarter. Bessemer Group Inc. grew its holdings in shares of Cardinal Health by 7,053.4% during the first quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock worth $158,491,000 after purchasing an additional 739,553 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after buying an additional 617,775 shares during the period. 87.17% of the stock is currently owned by institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.